Showing results (631-640 of 642) with videos related to

Sort By:
Pageof 65
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach]T Toge, M Fujita, K Hirata, et al.
Nature Communications|November 18, 2023
Antiferromagnetic topological insulator with selectively gapped Dirac conesA Honma, D Takane, S Souma, et al.
Lupus|February 1, 2019
Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohortK Ichinose, M Kitamura, S Sato, et al.
British Journal of Pharmacology|June 19, 2003
Retinoids as a potential treatment for experimental puromycin-induced nephrosisV Moreno-Manzano, F Mampaso, J C Sepúlveda-Muñoz, et al.
Lupus|February 14, 2019
Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort studyK Ichinose, M Kitamura, S Sato, et al.
Nature Communications|April 18, 2025
Spin-valley coupling enhanced high-TC ferromagnetism in a non-van der Waals monolayer Cr2Se3 on grapheneC-W Chuang, T Kawakami, K Sugawara, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 27, 2010
Interlaboratory Validation of the In Vitro Eye Irritation Tests for Cosmetic Ingredients. (6) Evaluation of MATREX((TM))J Ohuchi, Y Kasai, K Sakamoto, et al.
International Journal of Oncology|June 15, 2000
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissuesK Mori, M Hasegawa, M Nishida, et al.
Journal of Dental Research|November 10, 2010
FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trialM Kitamura, M Akamatsu, M Machigashira, et al.
The Japanese Journal of Antibiotics|August 21, 2001
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1999). I. Susceptibility distribution]Y Kumamoto, T Tsukamoto, K Watanabe, et al.
Pageof 65